Whatever happened to the polypill?

“Whatever happened to the polypill?” my colleagues ask me when told about the status of fixed-dose combination therapy for cardiovascular disease prevention. While the concept has always seemed straightforward, the implementation of this apparently simple concept has proved more challenging than anticipated. More than a decade after the concept was introduced, the state of the ...

Already a member?

Login to keep reading.

© 2021 the limbic